ARCHIVES

Bone Marrow Transplant Survival Has Doubled In Young Patients

This article is from The Cancer Letter archive.

Vol. 34 No. 8 | August 26, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Starts “Exceptional Responders” Study

September 26, 2014

DRG Executives Names By DeVita as Director Of DEA; Other Sections Reportedly Made, Not Yet Approved

July 31, 1981

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

April 26, 1996

NCI Advisory Group, Other Cancer Meetings

July 25, 1986

The Cancer Letter Obtains “Confidential” Documents From Duke IRB Investigation

May 14, 2010

ACS Ask Stronger Federal Action Against Cigarettes

November 23, 1979